This is a combination of a drug and light technology for the purpose of accelerating the healing of wounds on the skin, ulcers, and elsewhere in the body. Both methods have been shown to accelerate wound healing, and combining the two will potentially result in more rapid healing than either would alone.
This is a combination of a drug and light technology for the purpose of accelerating the healing of wounds on the skin, ulcers, and elsewhere in the body. Both methods have been shown to accelerate wound healing, and combining the two will potentially result in more rapid healing than either would alone. The drug will be developed in both a gel release form and in an aerosolized form so it can be easily applied. This will be done either before, after, or during exposure to light specifically designed for this purpose.
Significant clinical benefits. Wound healing.
Would speed up the healing of wounds such as burns, traumatic injury such as severe abrasions, and surgical would healing. Potentially would help heal skin, ulcers, and elsewhere in the body.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 10,272,096 | 04/30/2019 | 2013-772 |
nitrosyl-cobinamide, low level light therapy, wound healing